| Lactose (India) Ltd | 142 Cr. | 113 | 244/84.3 | 31.4 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,169 Cr. | 383 | 479/192 | 86.3 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.4 Cr. | 43.6 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 45.3 Cr. | 30.9 | 31.0/17.0 | 108 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 53.9 Cr. | 71.6 | 128/69.7 | 14.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,056 Cr. | 1,951 | 2,286/1,275 | 21.9 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 317 Cr. | 13.0 | 19.0/10.8 | 19.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 807 Cr. | 1,709 | 1,999/635 | 27.9 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 93.8 Cr. | 18.8 | 32.0/17.0 | 25.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 885 Cr. | 301 | 449/219 | 7.90 | 133 | 0.83 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 6.82 Cr. | 2.74 | 9.28/2.11 | 3.88 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 458 Cr. | 472 | 490/210 | 69.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,456 Cr. | 1,022 | 1,565/988 | 40.3 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 53.2 Cr. | 0.26 | 1.12/0.25 | 3.50 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 37.0 Cr. | 14.1 | 26.3/7.10 | 18.0 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.61 Cr. | 9.51 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 162 Cr. | 453 | 859/431 | 9.15 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 77.2 Cr. | 77.2 | 92.5/26.1 | 146 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,462 Cr. | 1,381 | 2,452/1,334 | 45.0 | 174 | 0.77 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.6 Cr. | 45.0 | 88.7/36.1 | 44.7 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.8 Cr. | 5.51 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.3 Cr. | 115 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 61.1 Cr. | 112 | 114/9.41 | 42.1 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.3 Cr. | 37.5 | 80.0/33.0 | 45.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.30 Cr. | 21.0 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,314 Cr. | 538 | 1,028/492 | 26.4 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.3 Cr. | 20.2 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.1 | 43.7/17.4 | 50.9 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 88,761 Cr. | 2,149 | 3,055/2,115 | 53.3 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 213 Cr. | 370 | 524/241 | 21.9 | 123 | 1.22 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.5 Cr. | 40.8 | 62.6/26.7 | 91.4 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,207 Cr. | 1,173 | 1,365/994 | 19.9 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 148 Cr. | 237 | 303/159 | 141 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 796 Cr. | 79.6 | 123/74.0 | 20.6 | 32.6 | 1.89 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.8 Cr. | 29.7 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,786 Cr. | 1,682 | 1,902/919 | 61.6 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.10 Cr. | 0.62 | 1.45/0.55 | 102 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 206 Cr. | 26.9 | 68.0/26.0 | 13.2 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.45 Cr. | 7.60 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.62 | 6.57/2.82 | 308 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 59,372 Cr. | 27,985 | 37,000/25,260 | 39.4 | 1,888 | 1.70 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,422 Cr. | 708 | 972/550 | 26.8 | 226 | 0.71 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 183 Cr. | 65.3 | 100/31.3 | 51.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,869 Cr. | 1,589 | 1,740/632 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,667 Cr. | 1,334 | 1,870/1,110 | 395 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 814 Cr. | 232 | 330/154 | 18.9 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,077 Cr. | 796 | 808/270 | 17.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,122 Cr. | 444 | 839/432 | 21.4 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,504 Cr. | 1,067 | 1,595/991 | 21.3 | 768 | 0.94 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,28,445 Cr. | 3,794 | 3,882/2,886 | 59.3 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 940 Cr. | 103 | 294/98.0 | | 41.3 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,404 Cr. | 15.0 | 23.5/14.1 | 22.4 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,207 Cr. | 528 | 1,328/521 | 58.8 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,843 Cr. | 170 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,28,353 Cr. | 1,786 | 1,910/1,547 | 37.1 | 324 | 0.90 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,681 Cr. | 607 | 775/441 | 418 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,913 Cr. | 311 | 335/175 | 35.9 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,467 Cr. | 332 | 502/265 | 41.8 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,074 Cr. | 201 | 260/111 | 117 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,781 Cr. | 4,246 | 6,718/4,146 | 26.5 | 340 | 2.76 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,814 Cr. | 2,298 | 2,725/1,772 | 34.2 | 335 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,398 Cr. | 5,674 | 6,739/4,904 | 30.6 | 373 | 2.20 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 176 Cr. | 49.9 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,974 Cr. | 5,025 | 5,993/3,701 | 32.5 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 114 Cr. | 92.6 | 233/81.0 | 11.8 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,025 Cr. | 332 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,226 Cr. | 833 | 1,998/604 | 80.9 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,914 Cr. | 16,299 | 19,748/10,060 | 107 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 472 Cr. | 21.0 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,537 Cr. | 868 | 1,502/660 | 10.1 | 483 | 0.69 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,241 Cr. | 40.9 | 91.7/40.0 | 29.7 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,665 Cr. | 191 | 332/162 | 24.6 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 40.2 Cr. | 25.4 | 130/23.6 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 289 Cr. | 79.6 | 176/72.2 | 141 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 93,871 Cr. | 2,055 | 2,403/1,774 | 21.7 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 963 Cr. | 482 | 975/470 | 12.0 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,976 Cr. | 1,018 | 1,040/501 | 80.5 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 930 Cr. | 896 | 1,235/596 | 19.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 145 Cr. | 67.8 | 115/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 629 Cr. | 130 | 227/123 | 35.7 | 104 | 2.31 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 591 Cr. | 335 | 500/265 | 21.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,930 Cr. | 1,061 | 1,250/802 | 34.1 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,384 Cr. | 1,810 | 1,952/1,303 | 39.5 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,333 Cr. | 200 | 302/193 | 30.5 | 38.0 | 1.25 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,199 Cr. | 1,466 | 1,758/1,168 | 37.6 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,406 Cr. | 82.2 | 127/57.5 | 20.7 | 59.7 | 0.97 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 761 Cr. | 93.6 | 124/67.2 | 25.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,175 Cr. | 237 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 3,155 Cr. | 256 | 457/217 | 312 | 96.9 | 0.55 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,359 Cr. | 1,594 | 2,504/1,243 | 31.0 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,433 Cr. | 343 | 498/285 | 63.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,458 Cr. | 555 | 621/412 | 26.4 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,056 Cr. | 1,951 | 2,286/1,275 | 21.9 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,917 Cr. | 2,593 | 3,516/1,921 | 46.1 | 101 | 1.62 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 28,196 Cr. | 1,709 | 2,131/1,200 | 24.4 | 610 | 1.05 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,885 Cr. | 423 | 528/359 | 30.5 | 149 | 1.18 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,917 Cr. | 1,609 | 1,910/1,097 | 52.7 | 227 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,390 Cr. | 1,251 | 1,406/1,020 | 18.1 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,455 Cr. | 220 | 322/178 | 23.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,20,423 Cr. | 1,491 | 1,673/1,310 | 22.1 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,660 Cr. | 1,928 | 2,641/1,551 | 24.9 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 280 Cr. | 95.4 | 203/93.5 | 20.0 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,585 Cr. | 150 | 191/105 | 14.5 | 107 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 55.5 Cr. | 33.5 | 67.7/32.6 | 19.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,704 Cr. | 379 | 425/291 | 107 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,634 Cr. | 1,619 | 2,171/1,430 | 36.1 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 115 Cr. | 72.0 | 132/70.0 | 16.8 | 49.2 | 1.67 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 317 Cr. | 140 | 205/67.8 | 30.0 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,542 Cr. | 9,010 | 10,691/6,301 | 97.5 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,894 Cr. | 654 | 843/544 | 33.4 | 118 | 0.70 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 171 Cr. | 81.0 | 137/75.2 | 9.08 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,974 Cr. | 5,598 | 5,868/4,492 | 28.5 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,369 Cr. | 883 | 1,124/725 | 27.4 | 271 | 1.25 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 425 Cr. | 751 | 1,540/746 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,185 Cr. | 2,654 | 3,116/2,022 | 34.1 | 345 | 1.05 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,396 Cr. | 304 | 412/258 | 23.0 | 133 | 1.71 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,552 Cr. | 390 | 575/312 | 18.6 | 147 | 0.26 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,300.60 Cr | 1,152.20 | | 52.34 | 202.18 | 0.36% | 16.29% | 15.20% | 6.10 |